AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 290: E234-E242, 2006. First published September 13, 2005; doi:10.1152/ajpendo.00059.2005
0193-1849/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/2/E234    most recent
00059.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hougaku, H.
Right arrow Articles by Metter, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hougaku, H.
Right arrow Articles by Metter, E. J.

Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements

Hidetaka Hougaku,1,2 Jerome L. Fleg,3 Samer S. Najjar,3 Edward G. Lakatta,3 S. Mitchell Harman,4 Marc R. Blackman,5 and E. Jeffrey Metter1

1Clinical Research Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland; 2Osaka University Graduate School of Medicine, Osaka, Japan; 3Laboratory of Cardiovascular Sciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland; 4Kronos Longevity Research Institute, Phoenix, Arizona; and 5Laboratory of Clinical Investigation, National Center for Complimentary and Alternative Medicine, National Institutes of Health, Bethesda, Maryland

Submitted 10 February 2005 ; accepted in final form 6 September 2005

Circulating testosterone levels (T) decrease with age in men. Low T has been associated with coronary disease and with risk factors for atherosclerosis. This study examines the relationship in men between androgenic hormones and arterial stiffness, a major risk factor for cardiovascular events. T, sex hormone-binding globulin (SHBG), and dehydroepiandrosterone sulfate (DHEAS) were measured longitudinally over 33 yr (follow-up 11.8 ± 8.3 yr) in 901 men from the Baltimore Longitudinal Study of Aging, of whom 206 (68.1 ± 13.7 yr) underwent carotid duplex ultrasonography. The 901 men were used to characterize age-associated hormone levels by means of mixed-effects models. Hormone values were estimated for the 206 men at the time of ultrasonography. Free T index (FTI) was calculated by dividing T by SHBG. The arterial stiffness index was calculated from peak systolic and end diastolic diameters of the common carotid artery and simultaneous brachial artery blood pressure. T, FTI, and DHEAS were correlated negatively with age, pulse pressure (PP), and stiffness index (each P < 0.01), whereas SHBG was correlated positively with age and stiffness index (P < 0.01). However, T was the only hormone that predicted the stiffness index after adjustment for age, PP, fasting plasma glucose, body mass index, and total cholesterol. T values 5–10 yr before the carotid study also predicted the stiffness index (P < 0.05). Thus the adverse influence of low T on the cardiovascular system in men may be mediated in part via the effects of T on vascular structure and function.

testosterone; dehydroepiandrosterone; carotid ultrasonography; intimal medial thickness; coronary heart disease



Address for reprint requests and other correspondence: E. J. Metter, Clinical Research Branch, National Institute on Aging, Harbor Hospital, 5th Floor, 3001 South Hanover St., Baltimore, MD 21225 (e-mail: metterj{at}mail.nih.gov)




This article has been cited by other articles:


Home page
Age AgeingHome page
S. V. Getov, R. W. Lee, F. Dockery, and C. Rajkumar
Androgens, ageing and vascular function
Age Ageing, July 1, 2008; 37(4): 361 - 363.
[Full Text] [PDF]


Home page
J AndrolHome page
M. J. Walton, N. Kumar, D. T. Baird, H. Ludlow, and R. A. Anderson
7{alpha}-Methyl-19-Nortestosterone (MENT) vs Testosterone in Combination With Etonogestrel Implants for Spermatogenic Suppression in Healthy Men
J Androl, September 1, 2007; 28(5): 679 - 688.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. V. D'Amico, J. W. Denham, J. Crook, M.-H. Chen, S. Z. Goldhaber, D. S. Lamb, D. Joseph, K.-H. Tai, S. Malone, C. Ludgate, et al.
Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions
J. Clin. Oncol., June 10, 2007; 25(17): 2420 - 2425.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. V. D'Amico
Toward the Optimal Use of Androgen Suppression Therapy in the Radiotherapeutic Management of Prostate Cancer
J. Clin. Oncol., January 1, 2007; 25(1): 8 - 9.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. Arnlov, M. J. Pencina, S. Amin, B.-H. Nam, E. J. Benjamin, J. M. Murabito, T. J. Wang, P. E. Knapp, R. B. D'Agostino Sr., S. Bhasin, et al.
Endogenous sex hormones and cardiovascular disease incidence in men.
Ann Intern Med, August 1, 2006; 145(3): 176 - 184.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.